title: Targeting the renin-angiotensin system in patients with renal disease.
authors.affiliation: Department of Medical Genetics, University of Cambridge, Cambridge, UK. majd2@medschl.cam.ac.uk
authors.forename: Mark A J
authors.initials: MA
authors.lastname: Devonald
authors.forename: Fiona E
authors.initials: FE
authors.lastname: Karet
mesh_terms: D000804:Angiotensin II / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000075202:Contraindications; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007674:Kidney Diseases / Q000188:drug therapy*; D011507:Proteinuria / Q000188:drug therapy*; D012307:Risk Factors; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D014662:Vasoconstrictor Agents; D000804:Angiotensin II